DXCM
Price
$83.37
Change
-$2.09 (-2.45%)
Updated
Jul 11 closing price
Capitalization
53.47B
17 days until earnings call
PODD
Price
$289.32
Change
-$8.08 (-2.72%)
Updated
Jul 11 closing price
Capitalization
11.75B
26 days until earnings call
Interact to see
Advertisement

DXCM vs PODD

Header iconDXCM vs PODD Comparison
Open Charts DXCM vs PODDBanner chart's image
DexCom
Price$83.37
Change-$2.09 (-2.45%)
Volume$2.33M
Capitalization53.47B
Insulet
Price$289.32
Change-$8.08 (-2.72%)
Volume$507.51K
Capitalization11.75B
DXCM vs PODD Comparison Chart in %
Loading...
DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PODD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DXCM vs. PODD commentary
Jul 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DXCM is a Buy and PODD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 13, 2025
Stock price -- (DXCM: $83.37 vs. PODD: $289.32)
Brand notoriety: DXCM and PODD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: DXCM: 72% vs. PODD: 59%
Market capitalization -- DXCM: $53.47B vs. PODD: $11.75B
DXCM [@Medical Specialties] is valued at $53.47B. PODD’s [@Medical Specialties] market capitalization is $11.75B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DXCM’s FA Score shows that 0 FA rating(s) are green whilePODD’s FA Score has 1 green FA rating(s).

  • DXCM’s FA Score: 0 green, 5 red.
  • PODD’s FA Score: 1 green, 4 red.
According to our system of comparison, PODD is a better buy in the long-term than DXCM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DXCM’s TA Score shows that 1 TA indicator(s) are bullish while PODD’s TA Score has 4 bullish TA indicator(s).

  • DXCM’s TA Score: 1 bullish, 5 bearish.
  • PODD’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PODD is a better buy in the short-term than DXCM.

Price Growth

DXCM (@Medical Specialties) experienced а +0.53% price change this week, while PODD (@Medical Specialties) price change was -3.90% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.39%. For the same industry, the average monthly price growth was -0.20%, and the average quarterly price growth was -0.47%.

Reported Earning Dates

DXCM is expected to report earnings on Oct 23, 2025.

PODD is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Medical Specialties (+0.39% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DXCM($53.5B) has a higher market cap than PODD($11.8B). DXCM has higher P/E ratio than PODD: DXCM (106.11) vs PODD (57.17). PODD YTD gains are higher at: 10.821 vs. DXCM (7.201). DXCM has higher annual earnings (EBITDA): 917M vs. PODD (324M). DXCM has more cash in the bank: 2.72B vs. PODD (704M). PODD has less debt than DXCM: PODD (1.42B) vs DXCM (2.59B). DXCM has higher revenues than PODD: DXCM (3.62B) vs PODD (1.7B).
DXCMPODDDXCM / PODD
Capitalization53.5B11.8B453%
EBITDA917M324M283%
Gain YTD7.20110.82167%
P/E Ratio106.1157.17186%
Revenue3.62B1.7B213%
Total Cash2.72B704M387%
Total Debt2.59B1.42B183%
FUNDAMENTALS RATINGS
DXCM vs PODD: Fundamental Ratings
DXCM
PODD
OUTLOOK RATING
1..100
1473
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
90
Overvalued
PROFIT vs RISK RATING
1..100
10062
SMR RATING
1..100
4126
PRICE GROWTH RATING
1..100
5047
P/E GROWTH RATING
1..100
7272
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DXCM's Valuation (84) in the Medical Specialties industry is in the same range as PODD (90). This means that DXCM’s stock grew similarly to PODD’s over the last 12 months.

PODD's Profit vs Risk Rating (62) in the Medical Specialties industry is somewhat better than the same rating for DXCM (100). This means that PODD’s stock grew somewhat faster than DXCM’s over the last 12 months.

PODD's SMR Rating (26) in the Medical Specialties industry is in the same range as DXCM (41). This means that PODD’s stock grew similarly to DXCM’s over the last 12 months.

PODD's Price Growth Rating (47) in the Medical Specialties industry is in the same range as DXCM (50). This means that PODD’s stock grew similarly to DXCM’s over the last 12 months.

PODD's P/E Growth Rating (72) in the Medical Specialties industry is in the same range as DXCM (72). This means that PODD’s stock grew similarly to DXCM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DXCMPODD
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
67%
MACD
ODDS (%)
Bearish Trend 2 days ago
65%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 13 days ago
71%
Declines
ODDS (%)
Bearish Trend 20 days ago
72%
Bearish Trend 2 days ago
66%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
72%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
DXCM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PODD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
FOREX / NAMEPrice $Chg $Chg %
GBPCHF1.080.00
+0.37%
United Kingdom Pound - Switzerland Franc
AUDGBP0.490.00
+0.01%
Australian Dollar - United Kingdom Pound
CHFRUB97.63N/A
N/A
Switzerland Franc - Russia Ruble
USNZ39.41-0.19
-0.48%
Xtrackers Net Zero Pwy Par Alg US Eq ETF
CATH75.88-0.41
-0.54%
Global X S&P 500® Catholic Values ETF

PODD and

Correlation & Price change

A.I.dvisor indicates that over the last year, PODD has been loosely correlated with ISRG. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if PODD jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PODD
1D Price
Change %
PODD100%
-2.72%
ISRG - PODD
46%
Loosely correlated
-2.66%
BSX - PODD
45%
Loosely correlated
-0.64%
SYK - PODD
39%
Loosely correlated
-1.35%
MMSI - PODD
39%
Loosely correlated
-1.77%
PEN - PODD
35%
Loosely correlated
-2.43%
More